There has been the number of molecular alterations identified in lung cancer including oncogenes and tumor suppressor genes, such as Epidermal Growth Factor Receptor (EGFR), Anaplastic Lymphoma Kinase (ALK) which have high relative frequencies as molecular targets [22]. The gene discussed is ALK; the disease is lung carcinoma.